Cargando…
Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy
BACKGROUND: Immunotherapy with immune checkpoint inhibitors (ICI) has revolutionized cancer therapy. However, therapeutic targeting of inhibitory T cell receptors such as PD-1 not only initiates a broad immune response against tumors, but also causes severe adverse effects. An ideal future stratifie...
Autores principales: | Heumos, Simon, Dehn, Sandra, Bräutigam, Konstantin, Codrea, Marius C., Schürch, Christian M., Lauer, Ulrich M., Nahnsen, Sven, Schindler, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555072/ https://www.ncbi.nlm.nih.gov/pubmed/36221114 http://dx.doi.org/10.1186/s12935-022-02710-y |
Ejemplares similares
-
Small non-coding RNA transcriptome of the NCI-60 cell line panel
por: Marshall, Erin A., et al.
Publicado: (2017) -
A map of mobile DNA insertions in the NCI-60 human cancer cell panel
por: Zampella, John G., et al.
Publicado: (2016) -
Pharmacogenomics of in vitro response of the NCI-60 cancer cell line panel to Indian natural products
por: Sankaran, Hari, et al.
Publicado: (2022) -
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers
por: Hurwitz, Stephanie N., et al.
Publicado: (2016) -
On the Best Way to Cluster NCI-60 Molecules
por: Hernández-Hernández, Saiveth, et al.
Publicado: (2023)